Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Clin Oncol. Feb 24, 2022; 13(2): 147-158
Published online Feb 24, 2022. doi: 10.5306/wjco.v13.i2.147
Table 5 Selected studies that assessed first-line TPEx schema in patients with recurrent or metastatic head and neck cancer
Study type
ORR (%)
PFS (mo)
OS (mo)
Grade 3, adverse events (%)
Grade 4, adverse events (%)
Guigay et al[19]Phase 254157.66.014.57333
Guigay et al[14]Phase 25444.46.2149322
Bossi et al[15]Phase 2120151.77.0117333
Even et al[21]Retrospective30876.013.61710
Fuchs et al[22]Retrospective38506.310.8100